Cargando…
Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1990
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971582/ https://www.ncbi.nlm.nih.gov/pubmed/2257203 |
| _version_ | 1782134941541203968 |
|---|---|
| author | Mulder, N. H. Willemse, P. H. Schraffordt Koops, H. de Vries, E. G. Sleijfer, D. T. |
| author_facet | Mulder, N. H. Willemse, P. H. Schraffordt Koops, H. de Vries, E. G. Sleijfer, D. T. |
| author_sort | Mulder, N. H. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1971582 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1990 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19715822009-09-10 Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. Mulder, N. H. Willemse, P. H. Schraffordt Koops, H. de Vries, E. G. Sleijfer, D. T. Br J Cancer Research Article Nature Publishing Group 1990-12 /pmc/articles/PMC1971582/ /pubmed/2257203 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Mulder, N. H. Willemse, P. H. Schraffordt Koops, H. de Vries, E. G. Sleijfer, D. T. Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title | Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title_full | Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title_fullStr | Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title_full_unstemmed | Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title_short | Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. |
| title_sort | dacarbazine (dtic) and human recombinant interferon alpha 2a (roferon) in the treatment of disseminated malignant melanoma. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971582/ https://www.ncbi.nlm.nih.gov/pubmed/2257203 |
| work_keys_str_mv | AT muldernh dacarbazinedticandhumanrecombinantinterferonalpha2aroferoninthetreatmentofdisseminatedmalignantmelanoma AT willemseph dacarbazinedticandhumanrecombinantinterferonalpha2aroferoninthetreatmentofdisseminatedmalignantmelanoma AT schraffordtkoopsh dacarbazinedticandhumanrecombinantinterferonalpha2aroferoninthetreatmentofdisseminatedmalignantmelanoma AT devrieseg dacarbazinedticandhumanrecombinantinterferonalpha2aroferoninthetreatmentofdisseminatedmalignantmelanoma AT sleijferdt dacarbazinedticandhumanrecombinantinterferonalpha2aroferoninthetreatmentofdisseminatedmalignantmelanoma |